Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Internal Medicine (Tokyo, Japan)|June 17, 2008
Inflammatory pseudotumors in multiple organs associated with elevated serum IgG4 level: recovery by only a small replacement dose of steroidHiroto Tsuboi, Shigeko Inokuma, Keigo Setoguchi, et al.
Rheumatology (Oxford, England)|August 5, 2009
Factors associated with fatal outcome of leflunomide-induced lung injury in Japanese patients with rheumatoid arthritisTakeo Sato, Shigeko Inokuma, Akira Sagawa, et al.
Modern Rheumatology|December 10, 2014
Trend of patient characteristics and its impact on the response to adalimumab in patients with rheumatoid arthritis: post hoc time-course analysis of an all-case PMS in JapanHisashi Yamanaka, Masayoshi Harigai, Naoki Ishiguro, et al.
Internal Medicine (Tokyo, Japan)|December 2, 2011
Serum KL-6 level as an indicator of active or inactive interstitial pneumonitis associated with connective tissue diseasesSatoshi Doishita, Shigeko Inokuma, Hiromitsu Asashima, et al.
Internal Medicine (Tokyo, Japan)|November 17, 2015
Atypical Subacute Recurrence of Catastrophic Antiphospholipid Syndrome in a Japanese Female PatientMasanobu Horikoshi, Shigeko Inokuma, Erika Matsubara, et al.
Modern Rheumatology|October 10, 2006
Clinical characteristics of Pneumocystis carinii pneumonia in patients with connective tissue diseasesTakeo Sato, Shigeko Inokuma, Reika Maezawa, et al.
Annals of the Rheumatic Diseases|August 20, 2011
Postmarketing surveillance of tocilizumab for rheumatoid arthritis in Japan: interim analysis of 3881 patientsTakao Koike, Masayoshi Harigai, Shigeko Inokuma, et al.
The Journal of Rheumatology|August 3, 2013
Safety and effectiveness of 6 months' etanercept monotherapy and combination therapy in Japanese patients with rheumatoid arthritis: effect of concomitant disease-modifying antirheumatic drugsTakao Koike, Masayoshi Harigai, Shigeko Inokuma, et al.
The Journal of Allergy and Clinical Immunology|April 8, 2009
T-box 21 transcription factor is responsible for distorted T(H)2 differentiation in human peripheral CD4+ T cellsOsamu Kaminuma, Fujiko Kitamura, Shoichiro Miyatake, et al.
Modern Rheumatology|November 21, 2013
Safety and effectiveness of adalimumab in Japanese rheumatoid arthritis patients: postmarketing surveillance report of 7740 patientsTakao Koike, Masayoshi Harigai, Naoki Ishiguro, et al.
Pageof 6